A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease

Alzheimer disease (AD) is characterized by functional impairment in the neural elements and circuits underlying cognitive and memory functions. We hypothesized that fornix/hypothalamus deep brain stimulation (DBS) could modulate neurophysiological activity in these pathological circuits and possibly produce clinical benefits.

[1]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[2]  Justin L. Vincent,et al.  Disruption of Large-Scale Brain Systems in Advanced Aging , 2007, Neuron.

[3]  D. Gaffan,et al.  Addition of fornix transection to frontal-temporal disconnection increases the impairment in object-in-place memory in macaque monkeys , 2008, The European journal of neuroscience.

[4]  Laura E. Gibbons,et al.  Assessing Quality of Life in Older Adults With Cognitive Impairment , 2002, Psychosomatic medicine.

[5]  D. Schacter,et al.  The Brain's Default Network , 2008, Annals of the New York Academy of Sciences.

[6]  J. Votaw,et al.  Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[7]  Keith A. Johnson,et al.  Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia , 2009, Neuron.

[8]  Steven G Potkin,et al.  A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease , 2005, Nature Medicine.

[9]  S H Ferris,et al.  Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. , 1997, Alzheimer disease and associated disorders.

[10]  J. Aggleton,et al.  Impaired recollection but spared familiarity in patients with extended hippocampal system damage revealed by 3 convergent methods , 2009, Proceedings of the National Academy of Sciences.

[11]  C. Jack,et al.  Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease , 2009, Brain : a journal of neurology.

[12]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[13]  K. Davis,et al.  A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. , 1994, The American journal of psychiatry.

[14]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[15]  R. Wennberg,et al.  Memory enhancement induced by hypothalamic/fornix deep brain stimulation , 2008, Annals of neurology.

[16]  A. Wall,et al.  Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer’s disease , 2006, Journal of Neural Transmission.

[17]  A. Luxen,et al.  Fast [18F]FDG synthesis by alkaline hydrolysis on a low polarity solid phase support , 2002 .

[18]  O. Adeotoye.  Book Review:The Practical Handbook of Clinical Gerontology. Edited by L. L. Carstensen, B. A. Edelstein and L. Dornbrand. Sage, New York, 1996. No. of Pages: 717. , 1997 .

[19]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[20]  Philip G. F. Browning,et al.  Severe Scene Learning Impairment, but Intact Recognition Memory, after Cholinergic Depletion of Inferotemporal Cortex Followed by Fornix Transection , 2009, Cerebral cortex.

[21]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[22]  Cindee M. Madison,et al.  Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. , 2009, Brain : a journal of neurology.

[23]  A. Lang,et al.  High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor , 1997, Annals of neurology.

[24]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[25]  A. Lozano,et al.  Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression , 2008, Biological Psychiatry.

[26]  H. Engler,et al.  Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. , 2006, Brain : a journal of neurology.

[27]  B. Miller,et al.  Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.

[28]  Daniela Montaldi,et al.  A disproportionate role for the fornix and mammillary bodies in recall versus recognition memory , 2008, Nature Neuroscience.

[29]  C. Kyriacou,et al.  A constitutively active cryptochrome in Drosophila melanogaster , 2004, Nature Neuroscience.

[30]  Kaori Ito,et al.  Disease progression meta-analysis model in Alzheimer's disease , 2010, Alzheimer's & Dementia.

[31]  R D Pascual-Marqui,et al.  Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. , 2002, Methods and findings in experimental and clinical pharmacology.

[32]  Benjamin J. Shannon,et al.  Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.

[33]  G. Waldemar,et al.  Patient versus informant reported quality of life in the earliest phases of Alzheimer's disease , 2006, International journal of geriatric psychiatry.

[34]  C R Jack,et al.  Imaging and Biomarkers in Early Alzheimer's Disease and Mild Cognitive Impairment , 2009, Clinical pharmacology and therapeutics.

[35]  Sébastien Ourselin,et al.  Appearance modeling of 11C PiB PET images: Characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging , 2008, NeuroImage.

[36]  Sylvain Houle,et al.  Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms , 1997, Nature Medicine.

[37]  W. Cowan,et al.  A QUANTITATIVE STUDY OF THE FORNIX-MAMILLO-THALAMIC SYSTEM , 2005 .

[38]  J. B. Ranck,et al.  Which elements are excited in electrical stimulation of mammalian central nervous system: A review , 1975, Brain Research.

[39]  A. Strafella,et al.  Bilateral globus pallidus stimulation for Huntington's disease , 2004, Annals of neurology.

[40]  David Eidelberg,et al.  Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. , 2009, Brain : a journal of neurology.

[41]  J. Morris,et al.  Validity and Reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) , 1997 .

[42]  Efstathios D. Gennatas,et al.  Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. , 2010, Brain : a journal of neurology.

[43]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[44]  J. Dostrovsky,et al.  Phantom sensations generated by thalamic microstimulation , 1998, Nature.

[45]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[46]  W M COWAN,et al.  A quantitative study of the fornixmamillo-thalamic system. , 1957, Journal of anatomy.

[47]  D. Geschwind,et al.  Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease , 2009, Nature Medicine.

[48]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[49]  V. Dhawan,et al.  Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. , 1993, Radiology.

[50]  L. Mucke,et al.  Synaptic Depression and Aberrant Excitatory Network Activity in Alzheimer’s Disease: Two Faces of the Same Coin? , 2010, NeuroMolecular Medicine.

[51]  Seth Love,et al.  Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial , 2008, The Lancet.

[52]  R. Sperling,et al.  Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation , 2008, Proceedings of the National Academy of Sciences.

[53]  G. Alexander,et al.  Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. , 2002, The American journal of psychiatry.

[54]  J. Growdon,et al.  Treatment for Alzheimer's disease? , 1992, The New England journal of medicine.

[55]  A. Lozano,et al.  Deep Brain Stimulation for Treatment-Resistant Depression , 2005, Neuron.

[56]  A. Lozano,et al.  The regulation of adult rodent hippocampal neurogenesis by deep brain stimulation. , 2008, Journal of neurosurgery.

[57]  Keith A. Johnson,et al.  Functional Alterations in Memory Networks in Early Alzheimer’s Disease , 2010, NeuroMolecular Medicine.

[58]  K. Blennow,et al.  Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease , 2008, Annals of neurology.

[59]  K. Hamacher,et al.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[60]  G. Glover,et al.  Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive Control , 2007, The Journal of Neuroscience.

[61]  Li Shen,et al.  Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort , 2009, Current Alzheimer research.

[62]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[63]  A. Destée,et al.  Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. , 2005, The New England journal of medicine.

[64]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[65]  M J de Leon,et al.  Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. , 1992, Archives of neurology.

[66]  M. Greicius,et al.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.

[67]  A. Lang,et al.  Parkinson's disease. Second of two parts. , 1998, The New England journal of medicine.